Somaxon - SOMX denied - try again

* Says letter did not raise any clinical safety issues
* Co says FDA has requested for amended REMS
* Co intends to schedule meeting with FDA for guidance
* Shares tank 71.7 pct

Dec 7 (Reuters) - Somaxon Pharmaceuticals Inc said U.S. health regulators declined to approve its insomnia drug Silenor for the second time this year, sending its shares down 72 percent before the bell.
The company had previously received a complete response letter in February from the U.S. Food and Drug Administration, which raised issues regarding efficacy data. [ID:nBNG439722].
Somaxon resubmitted the new drug application (NDA) for Silenor in June.
In the most recent complete response letter, the FDA stated that the Silenor NDA did not meet the approval standard for efficacy.
The letter did not raise any clinical safety issues but the FDA has requested the company submit an amended risk evaluation and mitigation strategy (REMS), including a medication guide to be distributed with the product, in any resubmission, the company said.
Somaxon said it intends to schedule a meeting with the FDA to seek specific guidance because the most recent complete response letter did not contain any specific requirement to conduct any additional clinical work or other specific guidance.
Shares of Somaxon were trading at $1.00 before the bell. They had closed at $3.53 Friday on Nasdaq.

Bank of America - BTFO AH - cono!

Bank of America Corporation (NYSE: BAC) is going to soon be out of the TARP. The report was first out by CNBC’s Charlie Gasparino right after 5 PM that Bank of America is about to do a large capital raise to exit out of the TARP. The the Wall Street Journal reported that Bank of America will be exiting the TARP. Their figure for a capital raise is $20 billion in new capital. It is also noted that Greg Curl may become interim-CEO.

Bank of America has now confirmed the reports in a press release noting that Bank of America will repay the entire $45 billion in TARP to U.S. taxpayers. The bank will ask holders to approve an increase in shares and will use $26.2 billion in excess liquidity in the repayment here. Asset sales are to be approved by the Federal Reserve ($4 billion approximately). It noted approximately $18.8 billion in proceeds from common equity equivalent securities sales and about $1.7 billion through restricted stock issuance.

This will dwarf the GE-Comcast deal for NBC Universal all day Thursday. Ken Lewis has not yet left, but this will be a crowning moment for him that will clear the way for him to leave the firm under a clear sky. Still, it is hard to not make a point here that will fume many readers… Maybe Ken Lewis should just be kept on for another year.

And if you are a compensation critic from Main Street America on how much these executives make, the day after these funds are repaid this salary and compensation energy should be directed elsewhere.

Bank of America shares closed down 1.5% at $15.65 today, and shares are down 1.6% at $15.40 after the news. Yes, this is good news that the bank can get out of the TARP and can stop having to answer to public and government criticism. But this is going to be dilutive at a minimum, and likely will be dilutive AND leveraging to its balance sheet unless you are a straight debit and credit person.

Rosen Law Firm Announces Class Action Lawsuit Against Hemispherx Biopharma, Inc.

• • Hemispherx Biopharma, Inc.

NEW YORK, NY--(Marketwire - 12/02/09) - The Rosen Law Firm, P.A. announces that a class action lawsuit has been filed on behalf of all purchasers of Hemispherx Biopharma Inc. ("Hemispherx") (AMEX:HEB - News) securities between February 18, 2009 and October 30, 2009, inclusive (the "Class Period").

Related Quotes

Symbol	Price	Change
HEB	0.70	-0.50

{"s" : "heb","k" : "c10,l10,p20,t10","o" : "","j" : ""}

To join the Hemispherx class action, go to the website at http://www.rosenlegal.com or call Laurence Rosen, Esq. or Phillip Kim, Esq. toll-free at 866-767-3653 or email lrosen@rosenlegal.com or pkim@rosenlegal.com for information on the class action. The case is pending in the United States District Court for the Eastern District of Pennsylvania.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER. YOU MAY ALSO RETAIN COUNSEL OF YOUR CHOICE.

The Complaint alleges that during the Class Period, defendants misled investors regarding the status and time frame for approval of Hemispherx's New Drug Application ("NDA") for Ampligen with the U.S. Food and Drug Administration ("FDA"). Specifically, defendants failed to disclose that the FDA had requested several reports from the Company before the NDA could even be considered, thus delaying the possible approval of Ampligen by several months at a minimum. Then, on November 2, 2009, when the Company belatedly disclosed this information, the price of Hemispherx's securities dropped from $1.45 on the previous trading day to close at $1.13 on November 3, 2009, a drop of more than 20%. The lawsuit seeks to recover damages for investors resulting from the drop in the share price related to the alleged fraud.

A class action lawsuit has already been filed on behalf of Hemispherx shareholders. If you wish to serve as lead plaintiff, you must move the Court no later than January 11, 2010. If you wish to join the litigation or to discuss your rights or interests regarding this class action, please contact plaintiff's counsel, Laurence Rosen, Esq. or Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at lrosen@rosenlegal.com or pkim@rosenlegal.com.

HEB DENIED BY FDA -Hemispherx Biopharma

* FDA asks company to conduct additional study
* FDA asks for safety and efficacy data * Shares fall 45 pct to 66 cents in extended trade

Dec 1 (Reuters) - Hemispherx Biopharma Inc said U.S. health regulators did not approve its experimental drug Ampligen for the treatment of chronic fatigue syndrome, sending its shares down 45 percent in after-hours trade.
In a complete response letter to the company, the U.S. Food and Drug Administration stated that the two primary clinical studies submitted with the new drug application did not provide credible evidence of efficacy.
The FDA recommended at least one additional clinical study which shows a convincing effect and confirms safety in the target population, Hemispherx said in a statement.
The FDA also asked the company to resolve outstanding inspection issues at some of its facilities producing Ampligen, that included the facility located in New Brunswick, New Jersey and one of its third party manufacturing facilities, Hollister-Stier Laboratories.
Hemispherx said it has not determined the impact of the recommendations on timelines and overall cost of the program.
The company said it is reviewing the complete response letter and will seek an expedited meeting with the FDA to discuss its recommendations.
Shares of the company fell 45 percent to 66 cents in after market trade. They closed at $1.20 Tuesday on the American Stock Exchange.

laws of the market

Have read this over and over again from all kinds of different traders.........

SIX STEPS that every trader needs to know to succeed in the markets.

Step 1: A move begins with the sponsors (smart traders) who have insider knowledge as it relates to a particular stock or market. This information will move a market up or down depending on the insiders’ information. These buyers are smart, very smart, and recognize trading/investment opportunities very early in the markup cycle.

Step 2: Days, weeks, or sometimes months after a move has started, there is a brief mention in the electronic media (radio, cable, TV) or on one of the internet chat boards that a market has moved. The public hears for the first time and begins to get interested, but does not buy.

Step 3: A blurb of information appears in print media. The move also begins getting more exposure on blogs and internet message boards. The public starts paying a little more attention, and will buy a little bit.

Step 4: Wall Street and LaSalle Street brokers go into full hype mode and hawk the market to their customers. The public begins buying in greater volume.

Step 5: A full-blown front-page article appears about the particular stock or market in one of the major financial newspapers, magazines, or financial websites. This is often six months after the fact and after a market has shown its greatest appreciation. There is often heavy public buying, even a possible frenzy, as all media, brokers, and so-called “gurus” start to tout the market.

Step 6: As step 5 gets underway, the sponsors or smart traders begin to move out of the market and take their profits off the table.

Report Cites Big Shortfall In Reserves At A.I.G

An independent analysis of whether the insurance industry has been setting aside enough money to pay its claims estimates that the American International Group has a shortfall of $11.9 billion in its property and casualty business.

HEB squeezed again!

HEB squeezed yet again.

Emini's futures- HOLY SHIT-THIS IS UGLY!!!!!!

happy thanksgiving NOT- MININOVA R.I.P. :(

Mininova limits its activities to Content Distribution service

http://blog.mininova.org/articles/2009/11/26/mininova-limits-its-activities-to-content-distribution-service/

HEB got squeezed!

HEB up 10% since the call this morning.

heb

if heb hits 1.13.....then short squeze..will run to 1.20s for shizzle!

RTK news

Rentech (RTK) and General Electric (GE) are partnering with Australia's SYNGAS to develop diesel fuel from coal biomass in Australia , according to Adelaidenow. The project is expected to be worth $3B

AONE intraday spike BTFO!

AONE A123 Systems: Follow up on intraday spike-The pop in AONE is being attributed to a DOE announcement, in which the agency will award $620 million for projects around the country to demonstrate advanced Smart Grid technologies and integrated systems that will help build a smarter, more efficient, more resilient electrical grid. These 32 demonstration projects, which include large-scale energy storage, smart meters, distribution and transmission system monitoring devices, and a range of other smart technologies, will act as models for deploying integrated Smart Grid systems on a broader scale. This funding from the American Recovery and Reinvestment Act will be leveraged with $1 billion in funds from the private sector to support more than $1.6 billion in total Smart Grid projects nationally... Among the demonstrations, Detroit Edison's Advanced Implementation of A123s Community Energy Storage Systems for Grid Support was named. This project will install 20 CES units, 25kW/2hr each, into a system that includes a 1 MW storage device integrated into a solar system.

BAC

BAC Bank of America: Fitch places Bank of America’s Individual Rating on rating watch positive Fitch placed its ‘D’ Individual ratings for Bank of America and its operating subsidiaries on Rating Watch Positive. Fitch has affirmed the Issuer Default Ratings (IDRs) of BAC and its subsidiaries, which are derived from U.S. government support and continue to carry a Stable Rating Outlook. Ratings of long and short-term deposits, long-term and short-term debt, and subordinated debt (with the exception of First Republic Bank are affirmed… BAC’s overall risk profile has begun to improve, with the potential for requiring additional government support or needing to omit dividends on preferred stock beginning to recede. Accordingly, Fitch has upgraded the preferred stock rating of BAC to ‘BB-’ from ‘B.’ At the same time, Fitch has placed all preferred and trust preferred ratings of BAC and its affiliates on Rating Watch Positive. Earnings remain under pressure, as BAC posted a narrow loss to common shareholders in the most recent quarter after noncash and nonrecurring items are factored out. Asset quality problems remain severe, with loan loss provisions remaining high. However, with a recent slower rate of deterioration in problem assets the pace of reserve build has begun to decelerate, which could indicate the potential for a near-term peak in problem assets.

Ummm... GOLD is out of hand...

nutz. $GLD

Coffee Merger - GMCR

Diedrich Coffee, Inc. (NASDAQ: DDRX) is soaring on a ceffeinated buyout offer. Green Mountain Coffee Roasters, Inc. (NASDAQ: GMCR)) confirmed that it has submitted a proposal to acquire Diedrich Coffee for $30.00 per share in a transaction with a total enterprise value of approximately $247 million. Diedrich announced that its board of directors had determined that the Green Mountain offer constituted a superior proposal over the offer from Peet’s Coffee & Tea, Inc. (NASDAQ: PEET) and Diedrich also announced today that is has received a revised offer from Peet’s.

The new $30.00 per share in cash has no financing and no due diligence contingencies that will be through cash on hand and existing bank lines of credit. This offer represents a 47% premium to the closing market price of Diedrich common stock on November 2, 2009 and a 15% premium over the original cash and stock proposal from Peet’s. Here are the moves at 8:55 AM EST:

DDRX is up 27% at $33.20 on 92,000 shares
GMCR is down only 0.5% at $64.71 on 6,000 shares
PEET is down 2.5% at $37.07 on 8,2000 shares

B to the A to the C for the Mike to the D - BAC Bank of America

its on a downtrend. it broke out of the downtrend line today(with some vol.), positive sign.

as you can see, the 10dma is just below it.

More importantly, its gonna test the 50dma(16.57). Bro, if it breaks thru that and the recent high of 16.62, the next test is 17.90ish.

If i was holding BAC and I get a BO off the above levels, I would sell 1/2 and hold the rest to see if it hits the 17.90ish levels. If at any time you go more than .10 below the 10dma get the fuck out.


....be seeing you

CY Cypress Semiconductor

it gapped up and is currently flagging and holding. Its above the 50 day and currently in a doji(indecisive between buyers and sellers).

You can buy with a stop just below its 50day currently @ 9.66.

DRYS conversion of preferred

Not necessarily bad news.

the $280m conv. pref stock was priced at $5.36, with conversion price of 27.5% preminum over that price, equating to $6.87 and that begins 4th Qtr 2010 and ends 3Q 2011. Any sellers can convert anytime before 4Q 2010 at $7.61 but it's a mandatorily convertible in 4 equal increments matching contractual delivery dates of the newbuilding drillships.

Get a job and pay your mortgage - if you can?!

Mortgage loan delinquency (the ratio of borrowers 60 or more days past due) increased for the 11th straight quarter, hitting an all-time national average high of 6.25 percent for the third quarter of 2009. At the current rate, delinquencies would hit a one-year high this year.

SEMITOOL acquired by APPLIED

Semitool, Inc. (NASDAQ: SMTL) is being acquired by Applied Materials, Inc. (NASDAQ: AMAT) for $11.00 per share in cash, or $364 million. At 8:20 AM EST we have seen almost 4,000,000 shares of Semitool trade and shares are up 30% at $10.94. Average volume here is a mere 160,000 shares, so you can already rack this up as an exponential volume day. Semitool’s 52-week trading range was $1.86 to $9.73.

CERS HALTED - NEWS PENDING

the FDA released briefing documents ahead of Monday's Blood Products Advisory Panel . The firm said the FDA's language is positive and increases the likelihood of a positive outcome for Cerus . Shares are Outperform rated. PENDING

SPRINT

Sprint Nextel Corp. appears to be one the largest S&P gainers this morning. The only news was the repayment of a $1 billion loan, but real news out today causing the run-up is the Oppenheimer upgrade to OUTPERFORM from Neutral. The price target was also raised to $6.00 from a prior $4.00 price target. At 9:46 AM EST we have shares trading up almost 11% at $3.44 on 15.5 million shares. Average daily volume is 55 million shares and the 52-week trading range is $1.35 to $5.94. We would also note that this is already seeing options activity picking up this morning in the longer-dated expiration months.

GENZ - some good news FDA

Genzyme announced that it has received a complete response letter from the FDA regarding its application to market Lumizyme for the treatment of Pompe disease. In its letter, the agency stated that satisfactory resolution of deficiencies related to the Allston Landing manufacturing plant are required before the Lumizyme application can be approved. Genzyme believes the other elements of the Lumizyme review, such as the Risk Evaluation and Mitigation Strategy, the product label, and post-marketing requirements, have been satisfactorily addressed.

NABI in play today

Nabi Biopharmaceuticals (NASDAQ: NABI) is soaring on a report that it and GlaxoSmithKline (NYSE: GSK) have entered into an agreement for its NicVAX, a nicotine conjugate candidate vaccine for the treatment of nicotine addiction and the prevention of smoking relapse. GSK will pay an upfront non-refundable fee of $40 million at closing to Nabi and will receive an option to exclusively license NicVAX on a worldwide basis. Also received will be a license to develop follow-on next-generation nicotine vaccines using Nabi’s intellectual property. Nabi is eligible to potentially receive over $500 million in total fees if all hurdles are hit and goals are achieved. Nabi’s market cap is $180 million. At 8:23 AM EST we have seen only about 16,000 shares trade hands versus an average daily volume of 165,000 shares. But the gain is up 35% at $4.83. That will be a 52-week high if it holds as the prior range is $2.15 to $4.75

Japan continues growth

Japan's economy grew at an annualized 4.8% in Q3, the second straight quarter of expansion

SVA selected Shanghai Government - CHINA

Sinovac Biotech announced that it was selected by the Shanghai Government to supply its inactivated hepatitis A vaccine, Healive, to the public market of Shanghai . Out of the five vaccine manufacturers that participated in the bidding process, the Shanghai Government awarded Sinovac the entire hepatitis A vaccine purchase order, valued at RMB 20.6 million , or approximately $3M . Pursuant to the agreement, Sinovac will supply Healive over the next twelve months.

Sprint upgrade

Sprint Nextel Raised to Outperform at Credit Suisse.

$SPX 1100 here we fuckin come

say hi to a new temp support level for $SPX-----1100. We should hit it this week.

ENJOY IT while we have it.

earnings monday
FTK
SVA

Altus Pharmaceuticals - Bankruptcy - Halted

On November 11 , Altus Pharmaceuticals filed a voluntary petition for relief under Chapter 7 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Massachusetts . In connection with the Bankruptcy Filing, the Company has ceased all business activity and operations. The Company?s Chapter 7 case will be administered by the Bankruptcy Court as Case No. 09-20886.

Hemispherx Biopharma Faces Purported Class Action Suit - Law Firm

Hemispherx Biopharma Faces Purported Class Action Suit

...gp find out more on this and put it in comments....i dont feel like looking up anything on this piece of shit

ABK its breaking new resistance level

.83 wow :)

fuck you HEB

thank you

AH action - AIG May Be Able to Pay Back Fed Loan, Moody’s Say

AIG May Be Able to Pay Back Fed Loan, Moody’s Says

Nov. 9 (Bloomberg) -- American International Group Inc., the insurer bailed out by the U.S., will be able to repay its Federal Reserve credit line and “much or all” of the Treasury Department’s investment if financial markets stabilize, Moody’s Investors Service said today.

HERO gets UPGRADE...nice bee

Credit Suisse upgrades Hercules Offshore, HERO, to Outperform

EWBC - East West Bancorp UPGRADE

OIL TRADE

found this on the web.
there might be a trade here on OIL, keep a close eye on I-da.
look at the track, look at the density of the oil rigs
nuff respect to Dr Cane

Non-farm - UNEMPLOYMENT 10.2%

FANNIE MAE -- Requests Another $15B From Govt

Fannie Mae 3Q Loss Narrows; Requests Another $15B From Govt

Fannie Mae (FNM) posted a narrower third-quarter loss but reported $22 billion of credit-loss provisions and foreclosed-property costs as it continues to deal with spiking delinquency rates.
The mortgage financier, placed under conservatorship 14 months ago to prevent its potential implosion, requested another $15 billion of aid as part of the $200 billion package extended to it. Fannie has received $44.9 billion so far.
The company admitted in its quarterly report, filed late Thursday with the Securities and Exchange Commission, that it will likely need more money from the Treasury Department in the future and reiterated "we are dependent on the continued support of Treasury in order to continue operating our business."
Fannie shares fell 5 cents to $1.07. The stock through the close was up 47% this year.
Loss reserves jumped 20% during the quarter to $64.72 billion; the prior-year figure was $15.53 billion.
The serious delinquency rate--loans at least three months past due or awaiting foreclosure--rose to 4.72% from 3.94% in the second quarter and 1.72% a year earlier.
Meanwhile, Fannie's loss narrowed to $18.87 billion, or $3.47 a share, from $28.99 billion, or $13 a share, a year earlier. The prior year had a $21.4 billion charge to write down the value of potential offsets to future income taxes.
Revenue jumped 47% to $5.95 billion.
To deal with souring loans, the company said it modified 56,816 loans, nearly double the second-quarter figure. Meanwhile, foreclosed-property acquisitions more than doubled to 98,428.
Looking ahead, Fannie trimmed its 2009 home-price drop forecast to 6% from 7% to 12%.

KKR Financial - KFN BLOW UP AFTERHOURS

KKR Financial Profit Up 37% On Gains, Lower Interest Expense


DOW JONES NEWSWIRES

KKR Financial Holdings LLC's (KFN) third-quarter income grew 37% on a drop in interest expense and a gain on investments. The results widely beat expectations.
The company, which invests in corporate debt, has seen its stock drop about 80% since it listed in 2005, losing billions of dollars in market value amid the drop in the debt markets. It suspended its dividend payment last year amid a liquidity crunch but has recently improved its balance sheet.
KKR Financial is a unit of private-equity firm Kohlberg Kravis Roberts & Co., which, although it has benefited from the market rebound this year, still finds itself struggling with soured takeover bets, damaged lending markets and a skittish investor base.
The company posted income of $67.2 million, or 42 cents a share, up from $49 million, or 32 cents a share, a year earlier. Revenue fell 40% to $135.2 million.
The latest results included $21.2 million in net realized and unrealized gains on investments, while the prior year's results included $28.3 million in losses from investments.
In March, the company forecast earnings of about 30 cents a share for each quarter this year. Analysts surveyed by Thomson Reuters recently expected 15 cents.
Shares of KKR Financial were up 3.9% to $5.38 in after-hours trading.

as BORAT would say, "I LIKE"

KFN BTFO- if jobs is good, watch the fuck out!

KFN!!!!!!!!!!

bout to BO-if gets some vol.

UUP HALTED

Deutsche Bank Dollar Bullish ETF Runs Out of Shares

Nov. 5 (Bloomberg) -- The PowerShares DB US Dollar Index Bullish Fund ran out of shares and trading of the security was halted for about 45 minutes amid increased bets that the currency will rebound.

The fund, also known by its UUP ticker symbol, rose 2.1 percent to $22.98 at 2:34 p.m. in New York, surging from $22.49 when trading was halted at 1:06 p.m. The U.S. Dollar Index, a six-currency gauge of the greenback, added 0.2 percent to 75.76. Its price is 3.3 times higher than the UUP, down from a ratio of 3.36 yesterday and a 28-month high of 3.38 on Oct. 19.

Market Summary douchebags

Volume is light for this time of day. Breadth is bullish across the board. Advancing Issues: 2253 / Declining Issues: 672 -- for a ratio of 3.35 to 1. Advancing Volume: 355,742,500 / Declining Volume: 110,758,759 -- for a ratio of 3.21 to 1. New 52-Week Highs: 58 / New 52-Week Lows: 3.

FARO call - BEE

You will see several new products from us in the next 12 months and we have not scaled back on R&D to become an industry leader.

UUP Call Options Explosive

US Dollar Bullish Index (NYSE: UUP) has gone very active…. It has traded 109,000 calls early on with huge buying at November $23, 96% bought offer side, and already nearly 10X average call volume.

CISCO BEATS

Nov 4 (Reuters) - Cisco Systems Inc : * CEO says almost all its fiscal Q1 financial measurements were above or at high end of company's expectations * CEO says fiscal Q3 2009 felt like a bottom; Q4 was probably the beginning of upturn, a tipping point. * CEO says sees solid indication of economic recovery in most geographies

FOMC little change

Federal Open Market Committee notes said that economic activity has picked up since the group’s September meeting, but certainly not enough for the Fed to do anything about it. The FOMC said it will maintain the target range for the federal funds rate at 0 to 1/4 percent, and will purchase a total of $1.25 trillion of agency mortgage-backed securities and about $175 billion of agency debt. The amount of agency debt purchases, while somewhat less than the previously announced maximum of $200 billion, is consistent with the recent path of purchases and reflects the limited availability of agency debt.

market flat - everyone waiting for the FOMC (2:15pm)

....or maybe they are waiting to see who wins the world series.

Fannie Mae

Warren Buffett may join Goldman Sachs (NYSE:GS) in bidding for Fannie Mae (NYSE:FNM) tax credits

Oil inventories due any second now - USO - UCO

The latest weekly inventories data from Department of Energy in crude and oil products is adding more support and adding fuel to a fire in the commodity rally today. It looks like we are back to larger draw-downs that expected. We are watching the Oil Services HOLDRs (NYSE: OIH), the Ultra Oil & Gas ProShares (NYSE: DIG), the United States Oil (NYSE: USO) ETF and the iPath S&P GSCI Crude Oil Total Return Index ETN (NYSE: OIL) reactions based upon the supply data.

QTM - Quantum bonkers

HEB

HEB looking to fill the gap to 1.35

ABK - AMBAC soaring

Ambac Financial Group Inc. (ABK) swung to a third-quarter profit thanks to large mark-to-market gains on credit derivatives, which had cost the bond insurer billions in losses a year earlier.
Shares surged 27% premarket to $1.41. The stock, which has tripled from an all-time low in March, remained down 15% for the year through Tuesday.
A foray into insuring mortgage-backed securities, which soured along with the housing market and home loans, combined with weak consumer sentiment and economic contraction sent the bond-insurance industry into a tailspin. But the housing market has shown signs of stabilization and Ambac has been terminating some contracts with counterparties to reduce risk exposure.
Ambac, the nation's No. 2 bond insurer behind MBIA Inc. (MBIA), posted a profit of $2.19 billion, or $7.58 a share, compared to a year-earlier loss of $2.43 billion, or $8.45 a share. The latest results included $2.13 billion of mark-to-market gains on credit derivatives and $303 million in gains from reinsurance cancellations. The prior year had $2.71 billion in derivative losses.
Revenue was $2.69 billion, compared to year-earlier negative revenue of $2.32 billion. Both results are skewed by the derivative impacts. Meanwhile, earned net premiums fell 16% and net investment income rose 6.5%.
Loss and loss expenses fell 24% while claims paid surged 73% amid the continued credit-rating downgrades on residential mortgage-backed securities.
The company's loss and loss-expense reserve nearly doubled to $4.52 billion.

Short ONNN - on a weak tape

Longs ARM - KFN - if the tape is strong

click on image to enlarge numbnut

$SPX update

Another doji - as predicted - better than long nasty red candlesticks!
this time a shooting star - could be a trend changer

sandwiched between 50dma and 100dma- need to break 50 BADLY!

last two doji days was expected. Lots of indecisiveness with the Fed reporting tomorrow.

Holy STEC - Earnings report - Coño!

STEC, maker of solid-state drives, posted Q3 revenue of $98.3 million, up 54.3% from a year ago, and ahead of the Street at $96.6 million. Non-GAAP EPS of 50 cents a share beat the Street by 3 cents.

But unfortunately for STEC bulls, the Street’s focus will be on the company’s comment that one of its customers who had signed $120 million supply agreement for shipments covering the 2009 second half “might carry inventory” of its Zeus SSDs at year end, which they will carry into 2010. STEC said it has begun a strategic sales and marketing program to promote integration of SSD’s into that customer’s systems, but that if the program is not successful, Q1 2010 orders from this customer would be negatively affected.

For Q4, the company expects revenue of $101 million to $103 million, with non-GAAP EPS of 51-53 cents; the Street has been expecting $106 million and 52 cents.

45 minutes into the after-hours session, STEC is now down $7.46, or 32.2%, to $15.69.

GM reports sales rising

GM’s sales rose unexpectedly, by 4% in October to 177,603 cars and light trucks.

Sprint hostile takeover

Rumor of Sprint hostile takeover going around.
Will post when I hear something.

Iphone sales in China- only 5,000 in first weekend - APPLE

China Unicom (NYSE:CHU) released its earnings yesterday and as part of its comments to investors it said it had only sold 5,000 iPhones since it started offering the handset.

China Unicom posted moderately good earnings. Its first three quarter’s financial statement said the big cellular company had revenue of 114,928 million RMB and 9,338 million RMB in net income.

Unicom Chairman Chang Xiaobing said more than 1 million 3G subscribers had been signed up and that the launch of Apple’s iPhone would boost revenue in the fourth quarter. The firm did not give any more specific forecasts.

Union Pacific- Burlington Northern Santa Fe Corporation

Buffet is buying his own train set just in time for Christmas.

We always knew that Warren Buffett loved the railroad stocks. We also had for years heard Buffett talk about the prospects of a “whale of a deal” in large acquisitions. And now this morning he is showing just how much. Berkshire Hathaway Inc. (NYSE: BRK-A) is acquiring Burlington Northern Santa Fe Corporation (NYSE: BNI). The terms call for $100.00 per share in cash and stock, well above the $76.07 closing bell price yesterday. Buffett already had a huge stake of 76.77 million shares, so he is buying the 77.4% stake he does not already own. It turns out that Warren is finally doing his whale of a deal. The transaction is valued at approximately $44 billion, if you include $10 billion of outstanding BNI debt. That makes this the largest transaction in Berkshire Hathaway history.

$SPX - pure indecisiveness

Not until weds. @ 2:15 ( the fed) will we have any direction on this market. If interest rate language alters at all, equities are fucked. we are fucked. Until then, sit and watch.

news on HEB - Hemispherx Biopharma

Hemispherx Biopharma announced a two-prong Chronic Fatigue Syndrome, CFS- clinical mission for November and December 2009 . The company plans to widen its ongoing clinical programs in CFS by accelerating collaborations with a consortium of researchers who have just discovered a retroviral link to Chronic Fatigue Syndrome . A clinically validated test to detect retrovirus antibodies in patients plasma is also currently under development. The company also plans to complete all outstanding queries from the FDA regarding its New Drug Application -NDA- for Ampligen, an experimental therapeutic, during November and December, 2009


this piece of shit is trading @ 1.10 PM

CBOE Volatility Index reaching highs

the bounce didnt even last a fuckin day!
FUGLY!

Citigroup breaking down- could get FUGLY

Sprint sucks

Sprint (NASDAQ:S) is starting to downplay the importance of the Palm (NASDAQ:PALM) Pre compared to other smartphones it is marketing.

RIMM is done

Technically, headed to the $40s

nothing but a dead cat

don't trust this!

YRCW halted news

Noteholders Would Exchange $536.8M In Notes For Cmn, New Pfd Shrs.

NOT GOOD!

YRCW halted- news pending

FORD EARNINGS - UP BIG Pre Market

Ford Motor Co. (NYSE: F) is soaring on the company’s earnings report showing that the only non-bailout car company made $1 billion in the third quarter. It reported net income of $997 million, or $.28 per share, an improvement of $1.2 billion from the third quarter of 2008. Pre-tax operating profit totaled $1.1 billion, an improvement of $3.9 billion from a year ago. At 8:40 AM EST we have seen 6.4 million shares trade hands and the stock is up at $7.62 after closing at $7.00. Be advised that average volume is over 70 million shares.

CIT Group files for US bankruptcy - Run for zeee hillz!

According to The Wall Street Journal, CIT (NYSE:CIT) will file for Chapter 11 today. Bondholders will probably provide $4.5 billion in financing for a prepackaged bankruptcy. Senior creditors will likely get $.70 on $1. Carl Icahn, who offered that company $1 billion in financing, may be left out in the cold because CIT may not need the capital he has offered.

Taxpayers are likely to see their $2.3 billion investment in the firm go to zero.

The group that will lose the most money that fastest are the investors who have bought CIT shares over the last several weeks, betting the company would not have to go to court. Shares traded at $2.20 on September 29. One October 19 CIT traded at $1.21. Investing in CIT was a long shot and investors who put their capital into the stock are likely to watch the shares fall to a few pennies tomorrow morning.

Hemispherx BioPharma gets approved!

HEB got approved for sucking seed releasing objects.
congrates HEB holders!

Hemispherx BioPharma

what did i say BEE, wish i was wrong!

one green stick between two reds.
technically not good......fucked, we are!
$SPX breaking through all kids of support.....next stop 1027ish-DE PINGA!

aren't bears supposed to hibernate when the cold comes.



VIX going nutty today--LOL--did I say DE PINGA already?

Gimme an S

Sprint Reports Loss, Again

Sprint Nextel (S) reported third-quarter 2009 results with net loss per share of 17 cents, exceeding the Zacks Consensus Estimate of 15 cents and the year-ago loss per share of 11 cents.

The GDP is rising....and leon is getting larger

I wouldn't trust this bounce today. volume was weak. we need more confirmation.

Looky here

click here douchbag

wow

fuckn a! this is fun being long in this market

Citi- get out!

FACTBOX- Biggest changes in NYSE short interest

---

    NEW YORK, Oct 27 (Reuters) - Short interest in Citigroup Inc <C.N> rose
more than 50 percent in the first half of October, data from the New York Stock
Exchange showed, indicating increasing bearish sentiment in the stock.
  Bets on declines in shares of Xerox Corp <XRX.N> spiked more than
seven-fold, while interest in Fidelity National Information Services <FIS.N>
decreased almost 80 percent.
  Investors who "short" securities borrow shares and then sell them, waiting
for the stock to fall so they can buy the shares at the lower price, return
them to the lender and pocket the difference.
  Below are the five NYSE stocks that experienced the largest increases and
decreases in their total short positions during the first half of the month
according to information released by the exchange.
  The five companies with the largest overall short positions are also
listed.
  The latest date is as of Oct. 15, while the previous period's data is as of
Sept. 30.
  Data for total short interest in the exchange, expected after the market
close on Monday, was still not available on Tuesday morning.

COMPANY                       OCT 15       SEPT 30      NET CHANGE  PCT CHANGE
-----------------------------------------------------------------------------
FIVE BIGGEST INCREASES:
Citigroup Inc <C.N>        178,057,740    117,961,458   60,096,282    50.95 
Xerox Corp <XRX.N>          47,136,876      6,622,651   40,514,225   611.75
Pfizer Inc <PFE.N>         285,836,513    267,603,794   18,232,719     6.81
Merck & Co Inc <MRK.N>     195,283,992    179,324,501   15,959,491     8.90
CIT Group Inc <CIT.N>       81,042,082     66,738,960   14,303,122    21.43

FIVE BIGGEST DECREASES:
General Electric Co <GE.N> 111,894,884    129,973,862  -18,078,978   -13.91
EMC Corporation <EMC.N>     44,867,490     61,746,557  -16,879,067   -27.34
Cemex SAB de CV <CX.N>      28,861,512     45,442,185  -16,580,673   -36.49
Fidelity Nat Info  <FIS.N>   3,950,367     18,824,948  -14,874,581   -79.02
Harley-Davidson Inc <HOG.N> 33,323,909     39,873,552   -6,549,643   -16.43

FIVE BIGGEST POSITIONS:
Pfizer Inc <PFE.N>         285,836,513    267,603,794   18,232,719     6.81
Merck & Co Inc <MRK.N>     195,283,992    179,324,501   15,959,491     8.90
Citigroup Inc <C.N>        178,057,740    117,961,458   60,096,282    50.95
General Electric Co <GE.N> 111,894,884    129,973,862  -18,078,978   -13.91
Fannie Mae <FNM.N>         110,977,012    111,994,988   -1,017,976    -0.91

need to repost this...tomorrow will be telling $SPX

We have to go up tomorrow!

finnies doing a late afternoon rally into bell?

BAC
C
GS
JPM
etc..

New ride at Universal Studio

you're on it!......and its gonna cost you money beatch!

on the lighter side of things.....there's a woot-off going on so you can spend all your gains!
www.woot.com

is the bull dead?

Aug. S&P Case-Shiller Home Price Index

9:04 AM Aug. S&P Case-Shiller Home Price Index: -11.3% vs. -13.3% in July and -11.9% consensus. Nationally, home prices are at levels similar to fall 2003.

SVA on BO watch!

looks to be in BO mode, in the circled area. If volume follows through, should be a nice day for you SVA holders!

$SPX

The last three times the $SPX has dipped below the 20 day, it has come up strong. Though I dont think it will be the case this time, let's hope I'm wrong.

DRYS earnings

DRYS DryShips beats by $0.07, beats on revs (6.89 -0.14) Reports Q3 (Sep) earnings of $0.27 per share, excluding non-recurring items, $0.07 better than the First Call consensus of $0.20; revenues fell 30.4% year/year to $228.2 mln vs the $210.7 mln consensus. Co reported Q3 Time Charter Equivalent Rates of $32,887 per day, from $29,752 sequentially and $63,947 in the prior year's quarter... Co says, "Our drybulk fleet is now virtually fully fixed for the remainder of 2009 and 2010 and 77% fixed for 2011 at healthy levels and we are prepared to leverage the volatility in freight rates in the future through further vessel acquisitions. DRYS now has $1.44 bln in fixed EBITDA from its dry bulk and drilling units over the next 2.25 years and we are well positioned to take advantage of acquisition opportunities as they arise.

we need to wait for guidance tomorrow morning--8:30am GL

SELL BAC already

ARM got volume

BTFO! beatch!

CROX BTFO!

ARM

Morning gap filled for ARM....could take off from here....need volume

DAN getting ready for lift off

DAN!

DAN

DAN looks good on BO over .24

****Obama declares swine flu a national emergency******

WASHINGTON – President Barack Obama declared the swine flu outbreak a national emergency, giving his health chief the power to let hospitals move emergency rooms offsite to speed treatment and protect noninfected patients.

The declaration, signed Friday night and announced Saturday, comes with the disease more prevalent than ever in the country and production delays undercutting the government's initial, optimistic estimates that as many as 120 million doses of the vaccine could be available by mid-October.

Health authorities say more than 1,000 people in the United States, including almost 100 children, have died from the strain of flu known as H1N1, and 46 states have widespread flu activity. So far only 11 million doses have gone out to health departments, doctor's offices and other providers, according to the Centers for Disease Control and Prevention officials.

SVA - you might just get back to $10 bee---soon
DVAX
NVAX
BCRX (gonna go nutty)
INO

GNBT

and fuckin hopefully HEB

BCRX-monday morning locomotive

Press Release
Source: BioCryst Pharmaceuticals, Inc.
On 8:04 pm EDT, Friday October 23, 2009

BIRMINGHAM, Ala., Oct. 23 /PRNewswire-FirstCall/ — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX - News) today announced that the U.S. Food and Drug Administration (FDA), in response to a request from the U.S. Centers for Disease Control and Prevention (CDC), has issued an emergency use authorization (EUA) for the investigational anti-viral drug intravenous (i.v.) peramivir in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.

DRYS- looky what i found.

"In the dry bulk shipping sector, the Baltic Dry Index posted solid gains this week as Capesize Time Charter Equivalent Rates rose significantly. The cost of renting ships gained 12.9% this week to 3043, as indicated by the benchmark Baltic Dry Index (BDI)."
very nice...i like

this is interesting

Will someone please make some money on these picks-

BTFO bonanza

If the tape is strong then:

CRBC took off and looks to continue....if it does move up, it will be a beastly move! This is your 15-20% bee!

DRYS- on watch for monster move

NYT did a breakaway gap--could have some more momo

ENT about to BTFO if it prints 1.80 with volume

PLD with 13.20 & volume

TVL with any sign of upward movement and volume

FMBI 11.50 with volume --BTFO....BIG!

CROX 8.00 & up

***********ARM will continue to climb (im in it)*************

STX 16.25 higher***very nice

PRGN -BO from the bell

got more BOs, but this is enough.

remember, if tape is weak----all bets are off.

(as of right now, the futures contract i'm in on the $spx is up nice, lets see if it hold through opening).

$SPX

you put my hands upon your hip, and we dip, we dip, we dip...

Yesterdays dip is being bought out....nice!

not trading, but watching closely!

WTF! that was a scary sell-off

maybe its healthy

today

im short FCS... me sa thinks dis a stock is going to 8.25
long ARM on breakout...needs to hold the 9.29 as support or me is outta here

i'm fuckin pissed

no charts.

congrats on margin bee....careful



longs

LMRXF above 1.40

EGLE above 6.00

OCLR above 1.32

...there's actually plenty more (and SHORTS too)but I'm too fuckin pissed right to do this shit.

DRYS

blast from the past, post

http://breaktfo.blogspot.com/2009/10/this-aint-like-adams-apple-good-things.html

told ya!....did i buy aapl...not! but i hope you did. anyone, anyone? bueller?

SICK

JUST SICK....
CAT is looking at tacking on 12% in two days of trading. Coño!
PM up 6%

Nailed the dragon

got out of SDRG for a 30%er.
the lil penny stock that could.

cono!

$SPX

AIG

AIGs testing intraday lows, should wait for breakthru support, but fuck it... shorting it for a scalp

WOW CBS

Thank you

two more looking good

lil penny stock SDRG
CBS on BO above 13.40


KFN again!

Short AIG again

...for a quick scalp

long EXXI quick scalp

out

out of both pos.
KFN moved nice! still moving...wow.

nice $$ on both

...lookin for more BOs!

HOY

In on KFN on BO!
and short AIG @ 42.50 for breakdown



....more to come

the new american way

something i ran into on the net

It is the month of August, on the shores of the Black Sea. It is raining, and the little town looks totally deserted.

It is tough times, everybody is in debt, and everybody lives on credit.

Suddenly, a rich tourist comes to town.

He enters the only hotel, lays a 100 Euro note on the reception counter, and goes to inspect the rooms upstairs in order to pick one.

The hotel proprietor takes the 100 Euro note and runs to pay his debt to the butcher.

The Butcher takes the 100 Euro note, and runs to pay his debt to the pig grower.

The pig grower takes the 100 Euro note, and runs to pay his debt to the supplier of his feed and fuel.

The supplier of feed and fuel takes the 100 Euro note and runs to pay his debt to the town's prostitute that in these hard times, gave her "services" on credit.

The hooker runs to the hotel, and pays off her debt with the 100 Euro note to the hotel proprietor to pay for the rooms that she rented when she brought her clients there.

The hotel proprietor then lays the 100 Euro note back on the counter so that the rich tourist will not suspect anything.

At that moment, the rich tourist comes down after inspecting the rooms, and takes his 100 Euro note, after saying that he did not like any of the rooms, and leaves town.

No one earned anything. However, the whole town is now without debt, and looks to the future with a lot of optimism.

And that, ladies and gentlemen, is how the United States Government is doing business today.

DISMAL

que mierda
thank goodness i got yesterday after the negative reaction on C and GS.

morning trades...
MPG again-but it nailed me for a loss
short PENN and holding
Doubled down on BEE, bee.

no time for charts..

Be seeing you.....

MPG

Got in and out of MPG for a nice return.. looking to get in for secondary BO

update on $SPX

We broke out today. We are movin up more on strength, foggitabout it!
Have fun! Enjoy.


BTW, there's a plethora of BTFO setup's for tomorrow but I don't have time to post.

i told you so...I still love drugs

DVAX looks like its gonna gap up tomorrow after the run up into the bell.

Im holding @ 1.83

This name was good to me once, time to revisit

broke out of a tight range and soon will be testing a rez that's a fuckin year old....please fellas, keep an eye on this cause this motherfucker is going to break the fuck out. it had OUTSTANDING interest today(VOLUME). Im looking for a print @ 3.10 with volume then I'm off to the moon, bitches. douchbag say what?
.......WHAT!

10,000 and its not over....trust me pon dat my yute

if it isnt my main man Art Cashin....selassie I liveth everytime

EARNINGS TOMORROW MORNING-CRUCIAL SHIT HERE

earnings before bell----conf call @ 11am


earnings before bell----conf call @ 9am


good luck maricones

BAC intraday update

MNI

in MNI

BTFO's for tomorrow....all the previous ones had been hitting...except for BEE, bee